Sales decline 8.93% to Rs 762.01 crore
Net profit of Alembic Pharmaceuticals rose 7.27% to Rs 122.10 crore in the quarter ended September 2017 as against Rs 113.83 crore during the previous quarter ended September 2016. Sales declined 8.93% to Rs 762.01 crore in the quarter ended September 2017 as against Rs 836.74 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales762.01836.74 -9 OPM %23.1819.95 -PBDT184.16166.89 10 PBT158.53146.64 8 NP122.10113.83 7Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)